Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S15a pseudogene 11 (RPS15AP11) is a non-functional genomic element classified as a processed pseudogene related to the ribosomal protein S15a gene family[1][5]. Pseudogenes like RPS15AP11 are remnants of functional genes that have lost their protein-coding potential through mutation or duplication events. While RPS15AP11 does not produce a protein, transcripts have been suggested to act as competitive endogenous RNAs in certain immune cell types by binding microRNAs, thereby potentially influencing post-transcriptional regulation[4]. No direct protein function, molecular activity, or clinical targeting is attributed to RPS15AP11. Ribosomal protein S15a, by contrast, is a structural protein in the ribosome's 40S subunit, playing roles in protein synthesis, cell cycle, and viral responses[3][8][9], but these functions do NOT apply to RPS15AP11.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene 11 (RPS15AP11).